The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Association of DAZL expression with risk of recurrence in clinical stage 1 testicular germ cell tumors.
 
Alok Tewari
Stock and Other Ownership Interests - B.A.I. Biosciences; Moderna Therapeutics; Teladoc
Honoraria - UroToday
Consulting or Advisory Role - Best Doctors, Inc
 
Anis Hamid
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; MSD
Travel, Accommodations, Expenses - Astellas Pharma; MSD
 
Jiaming Huang
No Relationships to Disclose
 
Caiwei Zhong
No Relationships to Disclose
 
Wanling Xie
Consulting or Advisory Role - Convergent Therapeutics
 
Emily Rothmann
No Relationships to Disclose
 
Peter Nicholls
No Relationships to Disclose
 
Nathan Walk
Employment - Quest Diagnostics
 
Iva Brcic
No Relationships to Disclose
 
Angelika Terbuch
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); MSD (Inst); Roche (Inst)
 
Eliezer Mendel Van Allen
Stock and Other Ownership Interests - ervaxx; Genome Medical; Genomic Life; Manifold Bio; Microsoft; Monte Rosa Therapeutics; Riva Therapeutics; Serinus Bio; Syapse; Tango Therapeutics
Consulting or Advisory Role - ervaxx; Genome Medical; Genomic Life; Illumina; Janssen; Manifold Bio; Monte Rosa Therapeutics; Novartis; Riva Therapeutics; Serinus Bio; Syapse; Tango Therapeutics
Speakers' Bureau - Illumina
Research Funding - Bristol-Myers Squibb; Novartis; Sanofi (Inst)
Patents, Royalties, Other Intellectual Property - Patent on clinical interpretation algorithms using cancer molecular data (Inst); Patent on discovery of chromatin regulators as biomarkers of response to cancer immunotherapy (Inst); Patent on discovery of retained intron as source of cancer neoantigens (Inst)
Travel, Accommodations, Expenses - Roche/Genentech
 
Christopher Sweeney
Stock and Other Ownership Interests - Leuchemix
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Bayer; Cadence Pharma; Genentech/Roche; Janssen Biotech; Lilly; Pfizer; POINT Biopharma; Sanofi
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Dendreon; Janssen Biotech (Inst); Pfizer (Inst); Sanofi (Inst)
Patents, Royalties, Other Intellectual Property - Leuchemix, Parthenolide, Dimethylaminoparthenolide. Exelixis: Abiraterone plus cabozantinib combination